ONCT(Delisted)
OncternalยทNASDAQ
--
--(--)
ONCT fundamentals
Oncternal (ONCT) released its earnings on Nov 6, 2024: revenue was 494.00K (YoY +175.98%), beat estimates; EPS was -2.86 (YoY -1582.35%), beat estimates.
Revenue / YoY
494.00K
+175.98%
EPS / YoY
-2.86
-1582.35%
Report date
Nov 6, 2024
EPS
Revenue
Revenue & Expenses
ONCT has released its 2024 Q3 earnings report, with revenue of 494.00K, reflecting a YoY change of 175.98%, and net profit of -8.46M, showing a YoY change of 14.18%. The Sankey diagram below clearly presents ONCT's revenue sources and cost distribution.
Key Indicators
Oncternal (ONCT) key financial stats and ratios, covering profitability, financial health, and leverage.
Oncternal (ONCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Oncternal (ONCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Oncternal (ONCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Oncternal (ONCT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Oncternal (ONCT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
